In vivo results also shown that modulation of JAK2 and AT1Rs reduces the progression of hypertension and proteinuria in diabetic renal dysfunction (Forrester et al., 2018; El-Arif et al., 2022). The gene discussed is JAK2; the disease is hypertensive disorder.